A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...

Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...

England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...

Many people suffering from severe mental illnesses are significantly overweight. New weight loss medications may help extend life expectancy.

A trainer outlines how to perform his four-week weight-loss workout program to build healthier habits through balanced, achievable workouts.

Fruits are essential for a balanced diet and can aid in weight loss due to their fiber content and enzymes. Consuming fruits ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

T here's always a new headline about weight-loss drugs, whether it's sharing new data on how many pounds someone has lost or ...